Journal
JOURNAL OF CHEMICAL INFORMATION AND MODELING
Volume 59, Issue 10, Pages 4460-4466Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jcim.9b00490
Keywords
-
Categories
Funding
- National Cancer Institute (NCI) [R01 CA188015]
- US National Science Foundation (NSF) [DGE-1324585]
- Chicago Biomedical Consortium
- Searle Funds at The Chicago Community Trust
- NCI [P30 CA060553]
Ask authors/readers for more resources
MEK4, mitogen-activated protein kinase kinase 4, is overexpressed and induces metastasis in advanced prostate cancer lesions. However, the value of MEK4 as an oncology target has not been pharmacologically validated because selective chemical probes targeting MEK4 have not been developed. With advances in both computer and biological high-throughput screening, selective chemical entities can be discovered. Structure-based quantitative structure-activity relationship (QSAR) modeling often fails to generate accurate models due to poor alignment of training sets containing highly diverse compounds. Here we describe a highly predictive, nonalignment based robust QSAR model based on a data set of strikingly diverse MEK4 inhibitors. We computed the electrostatic potential (ESP) charges using a density functional theory (DFT) formalism of the donor and acceptor atoms of the ligands and hinge residues. Novel descriptors were then generated from the perturbation of the charge densities of the donor and acceptor atoms and were used to model a diverse set of 84 compounds, from which we built a robust predictive model.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available